NAD+: start with the molecule
A readable introduction to NAD biology and the gap between an interesting mechanism and a useful treatment.
THE CELLULAR HEALTH EDITION / 01
NAD+ is part of a fascinating story.
Let’s look at what the science actually says.

Biology explains why researchers are interested.
A blood result and a lived benefit are different endpoints.
A product page needs its own close reading.
START HERE
A readable introduction to NAD biology and the gap between an interesting mechanism and a useful treatment.
Three related names, different interventions, and a practical way to read the research without mixing them up.
Compare NAD+ routes through evidence, clinical oversight, preparation, and practical commitments.
TRY THE EVIDENCE EXPLORER
Compare three papers by product, people, and measurement. See what each can—and cannot—tell you.
Put a paper in focusREAD THE OFFER
CoreAge Rx has paid first placement. An injectable preparation and an oral supplement are different products; this is not a clinical ranking.
A disclosed featured-partner review of CoreAge’s NAD+ injectable page, advertised price, care model, and evidence limits.
An examination of the advertised injection service, introductory billing, survey claims, and pharmacy questions.
A review of an oral NR-plus-pterostilbene supplement, its published trial, and the difference between a biomarker and a benefit.
THE GEOGRAPHY OF CARE
Search the state and city index, then verify clinical access. Geography is a starting point, not proof of a clinic.